GADETIN Research Institute has achieved a major scientific breakthrough with the development of a proprietary microencapsulation peptide delivery system that dramatically increases the bioavailability and efficacy of anti-aging active ingredients. The new technology has been granted international patent protection.

Key findings from the clinical study include:

• 340% increase in active ingredient absorption compared to conventional delivery systems

• 92% of clinical trial participants showed visible reduction in fine lines within 4 weeks

• Enhanced stability of peptide compounds extending shelf life by 200%

• Compatible with a wide range of formulation bases including serums, creams, and masks

The technology is now available for GADETIN OEM and ODM partners. Custom formulation development services incorporating the new delivery system can be completed in as little as 8 weeks.